These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 18551354

  • 1. Basic pharmacodynamic models for agents that alter the lifespan distribution of natural cells.
    Krzyzanski W, Perez-Ruixo JJ, Vermeulen A.
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):349-77. PubMed ID: 18551354
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic models for agents that alter production of natural cells with various distributions of lifespans.
    Krzyzanski W, Woo S, Jusko WJ.
    J Pharmacokinet Pharmacodyn; 2006 Apr; 33(2):125-66. PubMed ID: 16565883
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects.
    Pérez-Ruixo JJ, Krzyzanski W, Hing J.
    Clin Pharmacokinet; 2008 Apr; 47(6):399-415. PubMed ID: 18479174
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats.
    Ait-Oudhia S, Scherrmann JM, Krzyzanski W.
    J Pharmacol Exp Ther; 2010 Sep 01; 334(3):897-910. PubMed ID: 20501635
    [Abstract] [Full Text] [Related]

  • 5. An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects.
    Krzyzanski W, Perez-Ruixo JJ.
    Pharm Res; 2007 Apr 01; 24(4):758-72. PubMed ID: 17318417
    [Abstract] [Full Text] [Related]

  • 6. Basic pharmacodynamic models for agents that alter production of natural cells.
    Krzyzanski W, Ramakrishnan R, Jusko WJ.
    J Pharmacokinet Biopharm; 1999 Oct 01; 27(5):467-89. PubMed ID: 10948694
    [Abstract] [Full Text] [Related]

  • 7. Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.
    Freise KJ, Widness JA, Schmidt RL, Veng-Pedersen P.
    J Pharmacokinet Pharmacodyn; 2008 Jun 01; 35(3):285-323. PubMed ID: 18553126
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers.
    Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ.
    J Clin Pharmacol; 2004 Sep 01; 44(9):991-1002. PubMed ID: 15317827
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after intravenous and subcutaneous administration in rats.
    Woo S, Krzyzanski W, Jusko WJ.
    J Pharmacol Exp Ther; 2006 Dec 01; 319(3):1297-306. PubMed ID: 16973883
    [Abstract] [Full Text] [Related]

  • 10. Population pharmacokinetics meta-analysis of recombinant human erythropoietin in healthy subjects.
    Olsson-Gisleskog P, Jacqmin P, Perez-Ruixo JJ.
    Clin Pharmacokinet; 2007 Dec 01; 46(2):159-73. PubMed ID: 17253886
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Erythropoietin-induced erythroid precursor pool depletion causes erythropoietin hyporesponsiveness.
    Yan X, Ait-Oudhia S, Krzyzanski W.
    Pharm Res; 2013 Apr 01; 30(4):1026-36. PubMed ID: 23187865
    [Abstract] [Full Text] [Related]

  • 13. Target-mediated pharmacokinetic and pharmacodynamic model of recombinant human erythropoietin (rHuEPO).
    Woo S, Krzyzanski W, Jusko WJ.
    J Pharmacokinet Pharmacodyn; 2007 Dec 01; 34(6):849-68. PubMed ID: 17943422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and pharmacodynamics of the erythropoietin Mimetibody construct CNTO 528 in healthy subjects.
    Pérez-Ruixo JJ, Krzyzanski W, Bouman-Thio E, Miller B, Jang H, Bai SA, Zhou H, Yohrling J, Cohen A, Burggraaf J, Franson K, Davis HM.
    Clin Pharmacokinet; 2009 Dec 01; 48(9):601-13. PubMed ID: 19725594
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics and pharmacodynamics of epoetin alfa once weekly and three times weekly.
    Cheung W, Minton N, Gunawardena K.
    Eur J Clin Pharmacol; 2001 Aug 01; 57(5):411-8. PubMed ID: 11599659
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.